Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Nonmydriatic Fundus Cameras Market Size & Growth Forecast 2026–2035, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 12283| Published Date: Apr-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Nonmydriatic Fundus Cameras Market size was estimated at USD 191.19 Million in 2025 and is projected to grow at a 6% CAGR from 2026 to 2035, attaining USD 342.39 Million by 2035. The industry revenue for 2026 is calculated at USD 201.17 million.

Base Year Value (2025)
USD 191.19 Million
CAGR (2026-2035)
6%
Forecast Year Value (2035)
USD 342.39 Million
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Nonmydriatic Fundus Cameras Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads with 39.64% share, driven by routine retinal imaging adoption, integrated diabetic retinopathy screening workflows, and strong access to advanced diagnostic equipment across clinical settings.
  • Asia Pacific is growing at a 6.78% CAGR due to rising demand for high-volume, efficient eye screening and wider adoption of fast, non-dilated retinal imaging in resource-constrained care settings.

Segment Momentum

  • Tabletop systems held a 53.55% market share in 2025 due to their routine use in structured clinical settings, where stable image capture, consistent workflows, and dependable retinal imaging support everyday diagnostic practice.
  • Ophthalmic & optometrist offices are the fastest-growing end-use segment as retinal imaging becomes part of routine consultations, enabling earlier screening and more efficient in-office patient assessment.

Market Expansion Drivers

  • Rising prevalence of diabetic retinopathy and glaucoma increasing demand for retinal screening technologies.
  • Advancements in high-resolution ophthalmic imaging improving diagnostic accuracy and workflow efficiency.
  • Expanding preventive eye care programs boosting adoption of rapid noninvasive retinal examinations.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Major players in the nonmydriatic fundus cameras market include Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Canon Medical Systems Corporation (Japan), NIDEK Co., Ltd. (Japan), Kowa Company, Ltd. (Japan), Optomed Plc (Finland), Haag-Streit AG (Switzerland), Optos plc (United Kingdom).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising prevalence of diabetic retinopathy and glaucoma increasing demand for retinal screening technologies

A growing burden of diabetic retinopathy and glaucoma is pushing providers to screen larger patient pools earlier and more routinely, which is strengthening demand in the nonmydriatic fundus cameras market. These conditions often progress with limited symptoms, so ophthalmology clinics, diabetes centers, and primary care networks are placing greater emphasis on fast retinal assessment that can be performed without pharmacologic dilation. That practical advantage makes nonmydriatic systems well suited for high-throughput screening pathways, where clinicians need image capture that supports referral decisions, follow-up planning, and documentation without disrupting patient flow.

Advancements in high-resolution ophthalmic imaging improving diagnostic accuracy and workflow efficiency

Improvements in image resolution, clarity, and capture speed are influencing purchasing decisions in the nonmydriatic fundus cameras market by making these systems more clinically dependable in routine screening and follow-up. Providers are more willing to integrate nonmydriatic imaging into frontline care when sharper retinal visualization reduces unreadable images and limits the need for repeat examinations or specialist escalation solely due to poor image quality. As imaging performance improves alongside more streamlined software and acquisition interfaces, the equipment fits more easily into busy outpatient settings where staff efficiency and consistent diagnostic output directly shape technology adoption.

Expanding preventive eye care programs boosting adoption of rapid noninvasive retinal examinations

The expansion of preventive eye care initiatives is contributing to market size growth in the nonmydriatic fundus cameras market by shifting retinal assessment closer to routine, population-level screening. Public health programs, employer-backed vision checks, and community outreach models typically require examinations that are quick, tolerable, and easy to deploy outside highly specialized ophthalmic environments, which favors nonmydriatic imaging. As these programs prioritize early detection and broader coverage, healthcare organizations increasingly invest in equipment that supports rapid noninvasive exams, efficient triage, and scalable screening workflows.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of diabetic retinopathy and glaucoma increasing demand for retinal screening technologies 2.00% High North America, Asia Pacific High Near Term
Advancements in high-resolution ophthalmic imaging improving diagnostic accuracy and workflow efficiency 1.70% Moderate Europe, North America Medium Mid Term
Expanding preventive eye care programs boosting adoption of rapid noninvasive retinal examinations 1.40% High Asia Pacific, Latin America Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
39.64% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading regional position in 2025, accounting for a 39.64% share of the nonmydriatic fundus cameras market. This leadership is supported by broad adoption of retinal imaging in routine eye care and chronic disease management, particularly where diabetic retinopathy screening and primary ophthalmic assessments are integrated into established clinical workflows. The region’s market activity is further supported by strong provider access to advanced diagnostic equipment, allowing clinics, hospitals, and specialty eye centers to incorporate nonmydriatic systems into day-to-day screening without the delays and patient burden associated with dilation.

Asia Pacific is projected to expand at a 6.78% CAGR over the forecast period, with growth in the nonmydriatic fundus cameras market being fueled by increasing use of efficient eye screening tools across large and diverse patient populations. Adoption is accelerating as providers seek faster, less resource-intensive retinal imaging for high-volume care settings, where streamlined examinations can improve screening reach and patient throughput. Demand is also being aided by the practical value of nonmydriatic imaging in settings that need accessible retinal assessment without adding complexity to the examination process.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Clinical Imaging Precision

Germany emphasizes high-accuracy nonmydriatic fundus cameras that integrate with ophthalmology and hospital imaging systems. Medical facilities in Germany continue investing in dependable diagnostic equipment that enhances workflow efficiency while supporting standardized eye disease screening.

France 🇫🇷

Community Screening Support

France promotes nonmydriatic fundus cameras for accessible retinal screening across hospitals and community healthcare facilities. Medical providers in France prioritize user-friendly imaging systems that improve diagnostic consistency while supporting preventive ophthalmic care programs.

Italy 🇮🇹

Outpatient Imaging Expansion

Italy emphasizes practical nonmydriatic fundus camera deployment in ophthalmology clinics and outpatient diagnostic centers. Healthcare providers in Italy continue adopting versatile imaging systems that simplify retinal examinations while improving clinical workflow efficiency.

Japan 🇯🇵

Preventive Vision Care

Japan focuses on nonmydriatic fundus cameras for preventive eye examinations and routine health screening. Healthcare institutions in Japan continue expanding compact, high-resolution imaging solutions that improve diagnostic efficiency while addressing the needs of an aging population.

South Korea 🇰🇷

Smart Imaging Integration

South Korea supports nonmydriatic fundus camera adoption through digital healthcare initiatives and advanced ophthalmic diagnostics. Providers in South Korea increasingly integrate imaging platforms with AI-assisted analysis to streamline retinal assessments and improve patient management.

United States 🇺🇸

Digital Eye Diagnostics

The U.S. nonmydriatic fundus cameras market prioritizes efficient retinal imaging across hospitals, clinics, and primary care settings. Healthcare providers in the U.S. increasingly adopt AI-compatible imaging systems that improve screening workflows and support earlier detection of retinal diseases.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Nonmydriatic Fundus Cameras Market Share (%), Type, 2025

Tabletop
Handheld

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Type Segment Analysis: Tabletop (Largest Segment) vs Handheld (Fastest-Growing Segment)

Tabletop held the leading position in the nonmydriatic fundus cameras market in 2025, accounting for a 53.55% share. Its leadership is underpinned by routine use in structured clinical environments where stable image capture, consistent workflow integration, and operator familiarity matter most. In the nonmydriatic fundus cameras market, tabletop systems remain the preferred choice for facilities managing steady patient volumes because they fit established examination setups and support dependable retinal imaging in day-to-day diagnostic practice.

Handheld is emerging as the fastest-growing segment in the nonmydriatic fundus cameras market as eye screening increasingly moves beyond fixed examination rooms. Its momentum is tied to the practical need for portability in outreach settings, bedside use, and space-constrained practices where a full tabletop setup is less convenient. Compared with fixed systems, handheld devices are gaining traction because they allow providers to extend retinal imaging access more flexibly without relying on dedicated room-based infrastructure.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ophthalmic & Optometrist Offices (Fastest-Growing Segment)

Hospitals represented the largest end-use segment in 2025 in the nonmydriatic fundus cameras market, with a 47.49% share. Their leadership reflects the concentration of diagnostic equipment within multispecialty care environments that handle broad patient inflow and require dependable imaging as part of standard ophthalmic assessment. In the nonmydriatic fundus cameras market, hospitals maintain this share through established procurement capacity, integrated care pathways, and regular use of retinal imaging across both routine and referral-based eye evaluations.

Ophthalmic & optometrist offices are the fastest-growing end-use segment in the nonmydriatic fundus cameras market because retinal imaging is becoming more embedded in front-line eye care delivery. Growth is being backed by the practical shift toward earlier screening and in-office assessment, where dedicated eye care providers can use nonmydriatic systems directly within routine consultations. Relative to larger institutional settings, these offices are gaining momentum as they bring imaging closer to the point of first examination and streamline patient evaluation within specialized practice workflows.

Segment Sub-Segment Largest Segment Fastest Growing
Type Tabletop, Handheld Tabletop Handheld
End-use Hospitals, Ophthalmology Clinics, Ophthalmic & Optometrist Offices Hospitals Ophthalmic & Optometrist Offices
Competitive Landscape

Competitive Landscape and Market Positioning

Prominent players in the nonmydriatic fundus cameras market:

1. Carl Zeiss Meditec AG (Germany)

2. Topcon Corporation (Japan)

3. Canon Medical Systems Corporation (Japan)

4. NIDEK Co. Ltd. (Japan)

5. Kowa Company Ltd. (Japan)

6. Optomed Plc (Finland)

7. Haag-Streit AG (Switzerland)

8. Optos plc (United Kingdom)

The nonmydriatic fundus cameras market is progressing through enhanced imaging clarity and diagnostic efficiency innovations. Continuous R&D is enabling more accurate and patient-friendly ophthalmic solutions. The market is also witnessing frequent upgrades aligned with clinical imaging needs.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Topcon Healthcare, Inc. Jul-24 Topcon Healthcare appointed Lance Patton as Chief Commercial Officer to lead its transition toward a direct sales and service model. The role focuses on commercial restructuring, integration of AI-enabled disease detection solutions, and development of customized ophthalmic imaging offerings to strengthen market positioning in diagnostic eye care solutions.
Optomed May-24 Optomed launched the Aurora AEYE handheld fundus camera integrated with artificial intelligence capabilities for rapid detection of mild diabetic retinopathy. The device enables point-of-care retinal screening in primary care settings, supporting early disease identification and expanding access to nonmydriatic ophthalmic imaging in decentralized healthcare environments.
NIDEK CO., LTD.; Orbis International Jan-24 NIDEK CO., LTD. and Orbis International partnered to enhance AI-based eye screening programs in Vietnam through the deployment of donated fundus cameras. The collaboration supports diabetic retinopathy screening initiatives and strengthens the integration of artificial intelligence into ophthalmic diagnostics across emerging healthcare markets.
Carl Zeiss Meditec AG Dec-23 Carl Zeiss Meditec AG acquired the Dutch Ophthalmic Research Center to expand its ophthalmic portfolio and digitally enabled workflow solutions. The acquisition strengthens its position in advanced eye care technologies by broadening its diagnostic imaging capabilities and enhancing its integrated ophthalmology solutions across multiple eye disease applications.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Nonmydriatic Fundus Cameras Market — Custom Segments

Segment Sub-Segment
No segment data available.

Nonmydriatic Fundus Cameras Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How much revenue does the nonmydriatic fundus cameras market generate?

The market size of the nonmydriatic fundus cameras is estimated at USD 201.17 million in 2026.

What is the forecasted size of the nonmydriatic fundus cameras industry?

Nonmydriatic Fundus Cameras Market size is forecast to climb from USD 191.19 million in 2025 to USD 342.39 million by 2035 expanding at a CAGR of over 6% during 2026-2035.

How is the rising burden of diabetic retinopathy and glaucoma reshaping retinal screening adoption across frontline care settings?

Increasing disease prevalence is driving earlier and more routine screening in clinics and diabetes centers, pushing adoption of nonmydriatic systems that enable high-throughput imaging without dilation while supporting faster referral and follow-up decisions in constrained outpatient workflows.

Why are preventive eye care programs becoming a key demand driver for nonmydriatic fundus camera deployment?

Preventive programs are expanding population-level screening needs, favoring quick, noninvasive retinal exams. This is increasing investment in scalable imaging systems that support rapid assessments, efficient triage, and broad access outside specialized ophthalmology environments.

Why do tabletop nonmydriatic fundus cameras lead the market?

Tabletop systems held a 53.55% market share in 2025 due to their routine use in structured clinical settings, where stable image capture, consistent workflows, and dependable retinal imaging support everyday diagnostic practice.

Which end-use segment is growing the fastest in the nonmydriatic fundus cameras market?

Ophthalmic & optometrist offices are the fastest-growing end-use segment as retinal imaging becomes part of routine consultations, enabling earlier screening and more efficient in-office patient assessment.

Why is North America leading the nonmydriatic fundus cameras market?

North America leads with 39.64% share, driven by routine retinal imaging adoption, integrated diabetic retinopathy screening workflows, and strong access to advanced diagnostic equipment across clinical settings.

How is Asia Pacific driving fastest growth in this market?

Asia Pacific is growing at a 6.78% CAGR due to rising demand for high-volume, efficient eye screening and wider adoption of fast, non-dilated retinal imaging in resource-constrained care settings.

What are the prominent companies operating in the nonmydriatic fundus cameras landscape?

Major players in the nonmydriatic fundus cameras market include Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Canon Medical Systems Corporation (Japan), NIDEK Co., Ltd. (Japan), Kowa Company, Ltd. (Japan), Optomed Plc (Finland), Haag-Streit AG (Switzerland), Optos plc (United Kingdom).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →